These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 30829611)
1. EGFLAM correlates with cell proliferation, migration, invasion and poor prognosis in glioblastoma. Chen J; Zhang J; Hong L; Zhou Y Cancer Biomark; 2019; 24(3):343-350. PubMed ID: 30829611 [TBL] [Abstract][Full Text] [Related]
2. Overexpression of HOXC10 promotes glioblastoma cell progression to a poor prognosis via the PI3K/AKT signalling pathway. Guan Y; He Y; Lv S; Hou X; Li L; Song J J Drug Target; 2019 Jan; 27(1):60-66. PubMed ID: 29768063 [TBL] [Abstract][Full Text] [Related]
3. EGFLAM exhibits oncogenic activity and shows promise as a prognostic biomarker and therapeutic target in glioblastoma. Li K; Zhu Q; Du S; Zhao Q; Ba D; Zeng X; Peng Q; Cai J; Zhao Y; Jin H; Qi L Int Immunopharmacol; 2024 Sep; 138():112625. PubMed ID: 38996666 [TBL] [Abstract][Full Text] [Related]
4. Up-regulated circular RNA hsa_circ_0067934 contributes to glioblastoma progression through activating PI3K-AKT pathway. Xin J; Zhang XY; Sun DK; Tian LQ; Xu P Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3447-3454. PubMed ID: 31081099 [TBL] [Abstract][Full Text] [Related]
5. Epithelial membrane protein 1 promotes glioblastoma progression through the PI3K/AKT/mTOR signaling pathway. Miao L; Jiang Z; Wang J; Yang N; Qi Q; Zhou W; Feng Z; Li W; Zhang Q; Huang B; Chen A; Zhang D; Zhao P; Li X Oncol Rep; 2019 Aug; 42(2):605-614. PubMed ID: 31233190 [TBL] [Abstract][Full Text] [Related]
6. TMEM17 Promotes Tumor Progression in Glioblastoma by Activating the PI3K/AKT Pathway. Wang S; Zhou Q; Yan S; Liu C; Li F; Feng D; He M Front Biosci (Landmark Ed); 2024 Aug; 29(8):285. PubMed ID: 39206901 [TBL] [Abstract][Full Text] [Related]
7. NAMPT: A potential prognostic and therapeutic biomarker in patients with glioblastoma. Guo Q; Han N; Shi L; Yang L; Zhang X; Zhou Y; Yu S; Zhang M Oncol Rep; 2019 Sep; 42(3):963-972. PubMed ID: 31322259 [TBL] [Abstract][Full Text] [Related]
8. NRBP1 promotes malignant phenotypes of glioblastoma by regulating PI3K/Akt activation. Zhang A; Peng S; Sun S; Ye S; Zhao Y; Wu Q Cancer Med; 2024 Aug; 13(16):e70100. PubMed ID: 39149873 [TBL] [Abstract][Full Text] [Related]
9. SMAGP knockdown inhibits the malignant phenotypes of glioblastoma cells by inactivating the PI3K/Akt pathway. Ni H; Ji D; Huang Z; Li J Arch Biochem Biophys; 2020 Nov; 695():108628. PubMed ID: 33049294 [TBL] [Abstract][Full Text] [Related]
10. Differential expression of miR16 in glioblastoma and glioblastoma stem cells: their correlation with proliferation, differentiation, metastasis and prognosis. Tian R; Wang J; Yan H; Wu J; Xu Q; Zhan X; Gui Z; Ding M; He J Oncogene; 2017 Oct; 36(42):5861-5873. PubMed ID: 28628119 [TBL] [Abstract][Full Text] [Related]
11. The Ig superfamily protein PTGFRN coordinates survival signaling in glioblastoma multiforme. Aguila B; Morris AB; Spina R; Bar E; Schraner J; Vinkler R; Sohn JW; Welford SM Cancer Lett; 2019 Oct; 462():33-42. PubMed ID: 31377205 [TBL] [Abstract][Full Text] [Related]
12. C-type lectin domain family 5, member A (CLEC5A, MDL-1) promotes brain glioblastoma tumorigenesis by regulating PI3K/Akt signalling. Fan HW; Ni Q; Fan YN; Ma ZX; Li YB Cell Prolif; 2019 May; 52(3):e12584. PubMed ID: 30834619 [TBL] [Abstract][Full Text] [Related]
13. LIM and SH3 protein 1 regulates cell growth and chemosensitivity of human glioblastoma via the PI3K/AKT pathway. Zhong C; Chen Y; Tao B; Peng L; Peng T; Yang X; Xia X; Chen L BMC Cancer; 2018 Jul; 18(1):722. PubMed ID: 29980193 [TBL] [Abstract][Full Text] [Related]
14. RabGEF1 functions as an oncogene in U251 glioblastoma cells and is involved in regulating AKT and Erk pathways. Fan H; Xin T; Dong X; Yang F; Zhang R; Feng S; He D; Guo H; Pang Q Exp Mol Pathol; 2021 Feb; 118():104571. PubMed ID: 33166495 [TBL] [Abstract][Full Text] [Related]
15. Wild‑type IDH1 affects cell migration by modulating the PI3K/AKT/mTOR pathway in primary glioblastoma cells. Shen X; Wu S; Zhang J; Li M; Xu F; Wang A; Lei Y; Zhu G Mol Med Rep; 2020 Sep; 22(3):1949-1957. PubMed ID: 32705169 [TBL] [Abstract][Full Text] [Related]
16. EMP1 regulates cell proliferation, migration, and stemness in gliomas through PI3K-AKT signaling and CD44. Wang J; Li X; Wu H; Wang H; Yao L; Deng Z; Zhou Y J Cell Biochem; 2019 Oct; 120(10):17142-17150. PubMed ID: 31111534 [TBL] [Abstract][Full Text] [Related]
17. Lysyl oxidase-like 1 predicts the prognosis of patients with primary glioblastoma and promotes tumor invasion Yuan GQ; Zhang G; Nie Q; Wang Z; Gao HZ; Jin GS; Zheng ZQ PeerJ; 2024; 12():e17579. PubMed ID: 38978755 [TBL] [Abstract][Full Text] [Related]
18. The mitochondria-related gene risk mode revealed p66Shc as a prognostic mitochondria-related gene of glioblastoma. Peng G; Feng Y; Wang X; Huang W; Li Y Sci Rep; 2024 May; 14(1):11418. PubMed ID: 38763954 [TBL] [Abstract][Full Text] [Related]
19. PRL-3 is a potential glioblastoma prognostic marker and promotes glioblastoma progression by enhancing MMP7 through the ERK and JNK pathways. Mu N; Gu J; Liu N; Xue X; Shu Z; Zhang K; Huang T; Chu C; Zhang W; Gong L; Zhao H; Jia B; Gao D; Shang L; Zhang W; Guo Q Theranostics; 2018; 8(6):1527-1539. PubMed ID: 29556339 [No Abstract] [Full Text] [Related]
20. SLC25A32 promotes malignant progression of glioblastoma by activating PI3K-AKT signaling pathway. Xue Z; Wang J; Wang Z; Liu J; Zhao J; Liu X; Zhang Y; Liu G; Zhao Z; Li W; Zhang Q; Li X; Huang B; Wang X BMC Cancer; 2023 Jun; 23(1):589. PubMed ID: 37365560 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]